Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

New Study Supports Transposon Theory Of Aging

XTALKS VITALS NEWS

As the DNA structure in key areas begins to loosen, transposons are allowed to insert themselves into other genes, potentially disrupting their function and affecting health.

Tweetables from this article:

Tweet: Researchers are hesitant to declare causation between #transposon activity and aging-related #health problems http://ctt.ec/h0033+Researchers are hesitant to declare causation between transposon activity and aging-related health problems.

Share this!

September 20, 2016 | by Sarah Hand, M.Sc.

A recent study has contributed further evidence that transposonsDNA elements capable of moving around the genome – could play a role in deteriorating health associated with advanced age. The research – published in the journal, Proceedings of the National Academy of Sciences – could aid development of life-extending treatments capable of counteracting the effects of transposons on health.

Previous studies have shown that the mechanisms which normally keep these transposons from migrating to other areas of the genome, namely the firmly wound structure of heterochromatin, deteriorate as we age. As the DNA structure in key areas begins to loosen, transposons are allowed to insert themselves into other genes, potentially disrupting their function and affecting health.

“In this report the big step forward is towards the possibility of a true causal relationship,” said Dr. Stephen Helfand, Brown University professor of biology and senior author of the study. “So far there have been associations and suggestions that to all of us make sense, but the difference in science is that you need the data to back up your opinion.”

Using green fluorescent protein (GFP) as a marker, the researchers were able to study the movement of transposons in the genome of Drosophila fruit flies. As the flies aged, Helfand and his colleagues noted an increase in transposon activity.



Interesting, the transposon activity did not increase linearly as the flies aged; transposon movement throughout the genome was at its peak as the flies began to die. “Flies reach a certain age and then it takes off more exponentially,” commented Dr. Jason Wood, faculty investigator on the project.

In another experiment, the research team found that feeding the flies a low-calorie diet was able to significantly delay the point at which transposon activity began to increase. Dietary changes have already been shown to be successful interventions at prolonging lifespan.

Helfand and his team also manipulated genes known to regulate DNA structure and organization into heterochromatin, which are conserved in both Drosophila and humans. The researchers found that upregulation of the gene Su(var)3-9 – a gene which induces DNA to form a heterochromatic structure – extended the flies’ lifespan by 20 days.

Despite the evidence provided by the multiple experiments performed in this study, the researchers are hesitant to declare causation between transposon activity and aging-related health problems. “They make a strong story,” said Helfand. “We're starting to put the flesh on the skeleton.”

Instead, co-author Wood speculates that transposons are likely just one piece of a complex aging puzzle. “There are lots of potential mechanisms that influence the aging process,” said Wood. “There are a lot of things going on, but we think this is one of them.”


Keywords: Transposon, DNA, Aging


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Gilead’s Newest Hepatitis C Drug Gets FDA Approval

July 21, 2017 - Dominant player in the chronic hepatitis C virus (HCV) market Gilead has received US Food and Drug Administration (FDA) approval for its newest treatment, Vosevi.

Featured In: Pharmaceutical News


Detecting Alzheimer’s Biomarkers in the Blood Could Improve Early Diagnosis

July 20, 2017 - In an effort to improve rates of early diagnosis and intervention, researchers at Washington University in St. Louis have developed a blood test that can detect some of the hallmarks of Alzheimer’s disease.

Featured In: Biotech News


Insurance Coverage Under the Affordable Care Act Supports Clinical Trial Enrollment, Says Study

July 20, 2017 - Since the Patient Protection and Affordable Care Act (ACA) was passed in 2010, insurance approval for patients wishing to participate in oncology clinical trials has increased, according to a recent study published in the journal, Clinical Cancer Research.

Featured In: Clinical Trial News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Manufacturing Control Strategies: What Pharmaceutical and Biotech Companies Need to Know

REGISTER FOR THESE WEBINARS

Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned


EDC and eSource: Combined for Better Data and Faster Insights


Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide


How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology


Copyright © 2016-2017 Honeycomb Worldwide Inc.